Potassium Iodide

ApprovedSmall molecule

DDawnrays Pharmaceutical (Holdings) Limited

Potassium Iodide is one of 253 small molecule programs targeting Duodenal Ulcer. It is currently in Approved.

Indications

Total Trials

Active Trials

252

Competitors

Pipeline

Status by Indication[3][1]

Indication

Duodenal UlcerActive, not recruiting

Mitral RegurgitationActive, not recruiting

HyperthyroidismActive, not recruiting

ThyroiditisActive, not recruiting

Eye DiseaseUnknown

Graves DiseaseActive, not recruiting

NeuroblastomaActive, not recruiting

UrolithiasisActive, not recruiting

Anemia (phenotype)Unknown

Metabolic AcidosisActive, not recruiting

Duodenal UlcerApproved

Active, not recruiting

Mitral RegurgitationPreclinical

Active, not recruiting

HyperthyroidismPhase 3

Active, not recruiting

ThyroiditisPreclinical

Active, not recruiting

Eye DiseasePreclinical

Unknown

Graves DiseasePhase 3

Active, not recruiting

NeuroblastomaPreclinical

Active, not recruiting

UrolithiasisApproved

Active, not recruiting

Anemia (phenotype)Preclinical

Unknown

Metabolic AcidosisPhase 2

Active, not recruiting

Showing 10 of 14 indications

Competition

Competitive Landscape

687 competitors in Heart Failure

#DrugCompanyPhaseTrials

Potassium Iodide

DDawnrays Pharmaceutical (Holdings) Limited

Approved

1 2

Brethine

Sanofi

Preclinical

1 3

LCZ696

Novartis

Preclinical

15 4

Zemplar

Activase

Bystolic

VVitae Pharmaceuticals Inc., an Allergan affiliate

Preclinical

4 7

Zoloft

VViatris Specialty LLC

Preclinical

2 8

Oraverse

LLife Extension Foundation Inc.

Preclinical

1 9

Kuvan

BioMarin Pharmaceutical

Preclinical

1 10

Statin

Bristol-Myers Squibb

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2026

Phase 2/3Recruiting

Trial

NCT05918029

Q1 2027

N/ANot yet recruiting

Women

NCT07202832

N/AActive, not recruiting

Study completion

NCT05389995

Q3 2027

Phase 1Not yet recruiting

Efficacy

NCT04651088

Q4 2027

Phase 1Not yet recruiting

Kidney Stone

NCT06819111

Clinical

Trials by Indication[1]

Withdrawn·—·N/A·NCT00120731

Sodium Bicarbonate as an Alternative to Potassium Citrate for Kidney Stones

Not yet recruiting·UUniversity of California, Los Angeles·Phase 1/2·NCT07408076·30 enrolled

Thyroid1 trial

Measurement of Iodolipids in the Thyroid Gland and Other Biological Samples

Unknown status·—·N/A·NCT05628506·20 enrolled

Trial1 trial

Bone in CKD Alkali Response (BICARb Pilot Trial)

Recruiting·—·Phase 2/3·NCT05918029·103 enrolled

24 more indications

High Blood Pressure1 trial

Dietary Counseling or Potassium Supplement to Increase Potassium Intake in Patients With High Blood Pressure

Completed·OOttawa Hospital Research Institute·Phase 3·NCT03809884·7 enrolled

Urolithiasis1 trial

A Study on the Effection of Potassium Citrate Extended-release Tablets on Urolithiasis Formation or Recurrence

Unknown status·DDawnrays Pharmaceutical (Holdings) Limited·Phase 4·NCT03007160·2,001 enrolled

Calcinosis1 trial

Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature

Unknown status·JJuan A. Arnaiz·Phase 3·NCT01756547·74 enrolled

Hypercalciuria1 trial

Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria

Completed·NNational Center for Research Resources (NCRR)·Phase 3·NCT00004284·300 enrolled

Kidney Stone1 trial

Role of Medication in Making Urine Less Acidic as Part of Kidney Stone Prevention

Not yet recruiting·UUniversity of Texas Southwestern Medical Center·Phase 1·NCT06819111·20 enrolled

Clinical Trial1 trial

A Randomized Clinical Trial to Evaluate the Effectiveness of Oral Potassium Citrate in Preventing Ureteral Stent Encrustation in Patients Undergoing Ureteroscopy for Uric Acid Kidney Stones

Active, not recruiting·ZZagazig University·Phase 2/3·NCT06819553·48 enrolled

Bone1 trial

Effect of Neutralization of Endogenous Acid Production on BMD and Bone Microarchitectural

Completed·KKantonsspital Baselland Bruderholz·Phase 3·NCT00509405·202 enrolled

Treatment1 trial

Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets

Recruiting·HHuashan Hospital·Phase 4·NCT06966635·312 enrolled

Heart Failure1 trial

Study of Drug Therapy for Pediatric Heart Failure

Unknown status·CChina National Center for Cardiovascular Diseases··NCT06039540·200 enrolled

Ventricular Function1 trial

Study of Innovative Drug Strategies in Improving Left Ventricular Function After Mitral Repair

Unknown status·CChina National Center for Cardiovascular Diseases··NCT06039592·164 enrolled

Mitral regurgitation1 trial

Study of Innovative Drug Treatment Therapy for Pediatric Mitral Regurgitation

Unknown status·CChina National Center for Cardiovascular Diseases··NCT06037434·122 enrolled

Efficacy1 trial

Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet

Not yet recruiting·UUniversity of Texas Southwestern Medical Center·Phase 1·NCT04651088·15 enrolled

Women1 trial

Urine Alkalinization for UTI in Women: RCT

Not yet recruiting·—·N/A·NCT07202832·50 enrolled

Uric Acid1 trial

Impact of Sodium Bicarbonate on 24-hour Urine Parameters in Hypocitriuric and Uric Acid Stone Formers

Recruiting·UUniversity of California, Irvine·Phase 1·NCT06335537·100 enrolled

Side Effects1 trial

Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate

Completed·UUniversity of Texas Southwestern Medical Center·N/A·NCT02665117·61 enrolled

Duodenal Ulcer1 trial

The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers

Completed·TThe Third Xiangya Hospital of Central South University·Phase 4·NCT03342456·184 enrolled

Metabolic Acidosis1 trial

Metabolic Acidosis in Renal Transplant Patients

Completed·UUniversity of Zurich·Phase 2·NCT00913796·30 enrolled

Metabolism1 trial

The Effects of Potassium Citrate on Bone Metabolism

Completed·WWeill Medical College of Cornell University·Phase 4·NCT00357331·83 enrolled

Pregnancy1 trial

Preventing Lack of Iodine During Pregnancy

Terminated·UUniversity Hospital, Toulouse·Phase 3·NCT00379535·374 enrolled

Hyperthyroidism1 trial

Effective Iodide Therapy for Untreated Patients With Graves' Hyperthyroidism Avoiding Thionamide Drugs With Many Side Effects

Completed·KKyushu University··NCT04686006·504 enrolled

Graves disease1 trial

Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease

Completed·UUniversity of Massachusetts, Worcester·Phase 4·NCT00946296·36 enrolled

Relapsed/Refractory1 trial

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

Completed·SSusan Knox·Phase 2·NCT00490009·9 enrolled

Radiation Therapy1 trial

Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy

Terminated·SStanford University·Phase 2·NCT00490490·8 enrolled

Unspecified3 trials

Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones

Recruiting·UUniversity of Texas Southwestern Medical Center·Phase 4·NCT06003348·25 enrolled

Potassium Citrate and Crystal Light Lemonade

Active, not recruiting·NNorthwestern University·N/A·NCT05389995·10 enrolled

MIBG With Dinutuximab +/- Vorinostat

Completed·NNew Approaches to Neuroblastoma Therapy Consortium·Phase 1·NCT03332667·45 enrolled

Sources

References

[1]
ClinicalTrials.gov — 34 trial records for Potassium Iodide. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Potassium Iodide compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Potassium Iodide. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Dawnrays Pharmaceutical (Holdings) Limited company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: DDawnrays Pharmaceutical (Holdings) Limited

Potassium Iodide

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2026

Q1 2027

Q3 2027

Q4 2027

Trials by Indication[1]

Neuroblastoma2 trials

Hypertension2 trials

Kidney Stones2 trials

Thyroid1 trial

Trial1 trial

High Blood Pressure1 trial

Urolithiasis1 trial

Calcinosis1 trial

Hypercalciuria1 trial

Kidney Stone1 trial

Clinical Trial1 trial

Bone1 trial

Treatment1 trial

Heart Failure1 trial

Ventricular Function1 trial

Mitral regurgitation1 trial

Efficacy1 trial

Women1 trial

Uric Acid1 trial

Side Effects1 trial

Duodenal Ulcer1 trial

Metabolic Acidosis1 trial

Metabolism1 trial

Pregnancy1 trial

Hyperthyroidism1 trial

Graves disease1 trial

Relapsed/Refractory1 trial

Radiation Therapy1 trial

Unspecified3 trials

References

Drug Info

Quick Facts

Related News